Beyond CAR-T: Building manufacturing strategies for the next generation of regenerative cell therapies

BlueskyReddit
Webinar Date: September 10, 2026
Time: 11:00 AM EDT
Duration: 1 hour
  • <<
  • >>

As cell and gene therapy shifts toward in vivo approaches and regenerative modalities — iPSCs, MSCs, HSCs, and beyond — sponsors face new challenges beyond traditional CAR-T manufacturing: bioreactor and culture system selection, analytical strategy, and potency assay development for cell types with far less manufacturing precedent. Add to that the complexity of scaling from 2D to 3D culture systems, cryopreservation strategies for increasingly complex formats, and navigating regulatory pathways that are still being defined for these emerging modalities, and technical development can quickly become a bottleneck. This webinar will cover how Kincell Bio is expanding its platform to support these next-generation programs, including practical considerations for bioreactor selection, analytical and potency assay development, and regulatory strategy for early-stage sponsors. Attendees will leave with a clearer framework for planning technical development and manufacturing readiness.

In this webinar you’ll learn:

  • Engage early with your CDMO to de-risk technical development timelines
  • Select bioreactor and culture systems suited to your specific cell type and scale
  • Prioritize analytical and potency assay development based on regulatory risk, not convenience
  • Build cryopreservation and viability strategy into process design from day one
  • Anticipate regulatory expectations for emerging modalities before they become blockers

Who should attend:

  • Process development scientists
  • CMC/regulatory affairs specialists
  • Program/project leads at emerging cell therapy companies
  • Technical operations and manufacturing strategy leads

Register Now

    Please complete the following information to register for this webinar. If you already have an account, and the information will be filled out for you.
  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • The webinar sponsors and CompareNetworks may use the information you have provided to contact you about this webinar and other related topics. For more information please refer to our privacy policy.
President and Chief Technology Officer
Kincell Bio
Senior Director, Business Development
Kincell Bio
Image Karen Langhauser
Editor-in-Chief
Cell & Gene Therapy Reviewt